Late porous polyethylene implant exposure after motility coupling post placement

American Journal of Ophthalmology

Volumn 138, Issue 3, 2004, Pages 420-424

  Cheng, Man Sim ^a,b   Liao, Shu Lang ^a   Lin, Luke L K ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLYETHYLENE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONJUNCTIVA DISEASE; CONTROLLED STUDY; DEMOGRAPHY; ENUCLEATION; EVISCERATION; EYE SURGERY; FEMALE; HUMAN; MALE; ORBIT IMPLANT; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REIMPLANTATION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DEVICE REMOVAL; EYE ENUCLEATION; EYE EVISCERATION; EYE MOVEMENTS; FEMALE; FOREIGN-BODY MIGRATION; FOREIGN-BODY REACTION; HUMANS; INFANT; MALE; MIDDLE AGED; ORBITAL IMPLANTS; POLYETHYLENE; POROSITY; PROSTHESIS IMPLANTATION; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 4444326534     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.04.059     Document Type: Article

References (22)

1. Dutton J.J. Coralline hydroxyapatite as an ocular implant. Ophthalmology. 98:1991;370-377
2. Christmas N.J., Gordon C.D., Murray T.G., et al. Intraorbital implants after enucleation and their complications a 10-year review. Arch Ophthalmol. 116:1998;1199-1203
3. Buettner H., Bartley G.B. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 113:1992;669-673
4. Goldberg R.A., Holds J.B., Ebrahimpour J. Exposed hydroxyapatite orbital implants. Report of six cases. Ophthalmology. 99:1992;831-836
5. Edelstein C., Shields C.L., De Potter P., Shields J.A. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology. 104:1997;1616-1621
6. Shields C.L., Shields J.A., De Potter P., Singh A.D. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc. 91:1993;177-189. discussion 189-195
7. Remulla H.D., Rubin P.A., Shore J.W., et al. Complications of porous spherical orbital implants. Ophthalmology. 102:1995;586-593
8. Oestreicher J.H., Liu E., Berkowitz M. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology. 104:1997;324-329
9. Shields C.L., Shields J.A., De Potter P. Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases. Arch Ophthalmol. 110:1992;333-338
10. el-Shahed F.S., Sherif M.M., Ali A.T. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants. Ophthal Plast Reconstr Surg. 11:1995;91-94
11. Berghaus A. Porous polyethylene in reconstructive head and neck surgery. Arch Otolaryngol. 111:1985;154-160
12. Bigham W.J., Stanley P., Cahill J.M. Jr, Curran R.W., Perry A.C. Fibrovascular ingrowth in porous ocular implants the effect of material composition, porosity, growth factors, and coatings. Ophthal Plast Reconstr Surg. 15:1999;317-325
13. Jordan D.R., Chan S., Mawn L., et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology. 106:1999;505-512
14. Lin C.J., Liao S.L., Jou J.R., Kao S.C., Hou P.K., Chen M.S. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol. 86:2002;394-396
15. Jordan D.R. Spontaneous loosening of hydroxyapatite peg sleeves. Ophthalmology. 108:2001;2041-2044
16. Blaydon S.M., Shepler T.R., Neuhaus R.W., White W.L., Shore J.W. The porous polyethylene (Medpor) spherical orbital implant a retrospective study of 136 cases. Ophthal Plast Reconstr Surg. 19:2003;364-371
17. Jordan D.R., Klapper S.R. A new titanium peg system for hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg. 16:2000;380-387
18. Lee S.Y., Jang J.W., Lew H., Kim S.J., Kim H.Y. Complications in motility PEG placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol. 46:2002;103-107
19. Kirnbauer R., Kock A., Neuner P., et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol. 96:1991;484-489
20. Soparkar C.N., Wong J.F., Patrinely J.R., Appling D. Epidermal and fibroblast growth factors enhance fibrovascular integration of porous polyethylene implants. Ophthal Plast Reconstr Surg. 16:2000;337-340
21. Kostick D.A., Linberg J.V. Evisceration with hydroxyapatite implant. Surgical technique and review of 31 case reports. Ophthalmology. 102:1995;1542-1548. ; discussion 1548-1549
22. Shields C.L., Shields J.A., De Potter P., Singh A.D. Problems with the hydroxyapatite orbital implant experience with 250 consecutive cases. Br J Ophthalmol. 78:1994;702-706